|4May 17, 9:29 PM ET

Gionco David 4

4 · STEMLINE THERAPEUTICS INC · Filed May 17, 2019

Insider Transaction Report

Form 4
Period: 2019-05-03
Gionco David
Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2019-05-03+15,000239,938 total
Footnotes (2)
  • [F1]Represents restricted shares that were subject to a performance-based milestone, which occurred on May 3, 2019. The restricted shares will vest one-third (5,000 shares) on each of May 3, 2020, 2021 and 2022, conditioned on the reporting person's continued service.
  • [F2]Of the 239,938 shares, 189,907 shares are restricted stock.

Documents

1 file
  • 4
    a4.xmlPrimary

    4